Stock Events

Stock Events

CellSeed 

¥299
10
+¥8+2.75% Today

Statistics

Day High
300
Day Low
294
52W High
668
52W Low
231
Volume
265,100
Avg. Volume
1,087,273
Mkt Cap
10.37B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13MayExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-11.17
-9.11
-7.06
-5
Expected EPS
N/A
Actual EPS
N/A

Financials

-444.87%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
386.55MRevenue
-1.72BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 7776.TSE. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap184.37B
Thermo Fisher Scientific offers products and services for research, analysis, discovery, and diagnostics, directly competing in the life sciences sector.
Danaher
DHR
Mkt Cap134.19B
Danaher Corporation operates in the life sciences field, providing technologies for cellular analysis which competes with CellSeed's regenerative medicine technologies.
Illumina
ILMN
Mkt Cap18.49B
Illumina, Inc. provides genomics solutions, competing in the broader biotechnology space with applications in personalized medicine that overlap with CellSeed's offerings.
Bio-Rad Laboratories
BIO
Mkt Cap7.54B
Bio-Rad Laboratories, Inc. offers a range of products for the life science research and clinical diagnostics markets, competing in the development of innovative technologies.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.17B
Regeneron Pharmaceuticals, Inc. is a biotechnology company that develops medicines for serious medical conditions, directly competing in the biopharmaceutical space with CellSeed.
Vertex Pharmaceuticals
VRTX
Mkt Cap110.97B
Vertex Pharmaceuticals Incorporated is known for creating new possibilities in medicine to cure diseases and improve people's lives, competing in the biotech sector.
Novo Nordisk
NVO
Mkt Cap167.44B
Novo Nordisk A/S focuses on diabetes care and other serious chronic conditions, which indirectly competes with CellSeed by offering alternative therapeutic approaches.
Pfizer
PFE
Mkt Cap153.13B
Pfizer Inc. is a global biopharmaceutical company that has a broad range of products in various areas, including biotechnology and regenerative medicine, making it a competitor.
Roche
RHHBY
Mkt Cap322.3B
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses worldwide, competing in the development of innovative drugs and technologies in the healthcare sector.

About

CellSeed Inc. develops regenerative medicine products primarily in Japan and internationally. It is involved in the research, development, and commercialization of cell-sheet regenerative medicine products, such as epithelial cell sheet for esophageal regeneration, regenerated cartilage sheet, and chondrocyte sheet for the treatment of knee osteoarthritis. The company also offers UpCell, a temperature-responsive cell cultureware for cell-sheet engineering; RepCell, a temperature-responsive cell cutureware for cell collection; and HydroCell, a low cell binding cultureware. In addition, it provides contract development and manufacturing services. The company was founded in 2001 and is headquartered in Tokyo, Japan.
Show more...
CEO
Ms. Setsuko Hashimoto
Employees
44
Country
Japan
ISIN
JP3423530009

Listings

TSE
JP
7776.TSE

0 Comments

Share your thoughts

FAQ

What is CellSeed stock price today?▼
The current price of 7776.TSE is ¥299 JPY — it has increased by +2.75% in the past 24 hours. Watch CellSeed stock price performance more closely on the chart.
What is CellSeed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange CellSeed stocks are traded under the ticker 7776.TSE.
Is CellSeed stock price growing?▼
7776.TSE stock has fallen by -0.33% compared to the previous week, the month change is a -8% fall, over the last year CellSeed has showed a -44.11% decrease.
What is CellSeed market cap?▼
Today CellSeed has the market capitalization of 10.37B
When is the next CellSeed earnings date?▼
CellSeed is going to release the next earnings report on May 13, 2026.
What were CellSeed earnings last quarter?▼
7776.TSE earnings for the last quarter are -7.12 JPY per share, whereas the estimation was N/A JPY resulting in a N/A surprise. The estimated earnings for the next quarter are N/A JPY per share.
What is CellSeed revenue for the last year?▼
CellSeed revenue for the last year amounts to 386.55M JPY.
What is CellSeed net income for the last year?▼
7776.TSE net income for the last year is -1.72B JPY.
How many employees does CellSeed have?▼
As of April 15, 2026, the company has 44 employees.
In which sector is CellSeed located?▼
CellSeed operates in the Health & Wellness sector.
When did CellSeed complete a stock split?▼
CellSeed has not had any recent stock splits.
Where is CellSeed headquartered?▼
CellSeed is headquartered in Tokyo, Japan.